Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary

Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary

BackgroundCancer of unknown primary (CUP) is heterogeneous and has a wide variety of clinical presentations and a poor prognosis in most patients, with a median overall survival of only 6 months. The development of molecular profiling contributes to precision therapy, and targeted drugs and immune c...

Full description

Bibliographic Details
Main Authors: Jie Mei, Hao Wang, Honghong Fan, Junli Ding, Junying Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
cancers of unknown primary
immunotherapy
PD-L1
molecular profiling
combinational therapy
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.900119/full

Similar Items

Similar Items